IRIS

BRULLO, CHIARA

BRULLO, CHIARA  

100006 - Dipartimento di Farmacia  

Mostra records
Risultati 1 - 20 di 105 (tempo di esecuzione: 0.019 secondi).
Titolo Data di pubblicazione Autore(i) File
1-Methyl and 1-(2-hydroxyalkyl)-5-(3-alkyl/cycloalkyl/phenyl/naphthylureido)-1H-pyrazole-4-carboxylic acid ethyl esters as potent human neutrophil chemotaxis inhibitors 1-gen-2009 Bruno, Olga; Brullo, Chiara; Bondavalli, Francesco; Schenone, Silvia; Spisani, S; Falzarano, Ms; Varani, K; Barocelli, E; Ballabeni, V; Giorgio, C; Tognolini, M.
2-Amino/Azido/Hydrazino-5-alkoxy-5H-[1]benzopyrano[4,3-d]pyrimidines: Synthesis and Pharmacological Evaluation 1-gen-2007 Bruno, Olga; Brullo, Chiara; Bondavalli, Francesco; Ranise, Angelo; Schenone, Silvia; M., Tognolini; V., Ballabeni; E., Barocelli
2-Aryl-3-phenylamino-4,5-dihydro-2h-benz[g]indazoles with analgesic activity 1-gen-2003 Schenone, Silvia; Bruno, Olga; Ranise, Angelo; Brullo, Chiara; Bondavalli, Francesco; W., Filippelli; F., Mazzeo; A., Capuano; G., Falcone
2-Phenyl-2,3-dihydro-1H-imidazo[1,2-b]pyrazole derivatives: New potent inhibitors of fMLP-induced neutrophil chemotaxis 1-gen-2007 Bruno, Olga; Brullo, Chiara; Bondavalli, Francesco; Ranise, Angelo; Schenone, Silvia; Falzarano, M. S.; Varani, K; Spisani, S.
3D QSAR models built on structure-based alignments of Abl tyrosine kinase inhibitors. 1-gen-2009 F., Falchi; F., Manetti; F., Carraro; A., Naldini; G., Maga; E., Crespan; Schenone, Silvia; Bruno, Olga; Brullo, Chiara; M. Botta, .
A combination strategy to inhibit Pim-1: synergism between noncompetitive and ATP-competitive inhibitors. 1-gen-2013 Mori, M; Tintori, C; Christopher, Rs; Radi, M; Schenone, Silvia; Musumeci, Francesca; Brullo, Chiara; Sanità, P; Delle Monache, S; Angelucci, A; Kissova, M; Crespan, E; Maga, G; Botta, M.
A1 receptors ligands: past, present and future trends. 1-gen-2010 Schenone, Silvia; Brullo, Chiara; Musumeci, Francesca; Bruno, Olga; Botta, M.
Ablation of specific long PDE4D isoforms increases neurite elongation and conveys protection against amyloid-β pathology 1-gen-2023 Paes, D.; Schepers, M.; Willems, E.; Rombaut, B.; Tiane, A.; Solomina, Y.; Tibbo, A.; Blair, C.; Kyurkchieva, E.; Baillie, G. S.; Ricciarelli, R.; Brullo, C.; Fedele, E.; Bruno, O.; van den Hove, D.; Vanmierlo, T.; Prickaerts, J.
Amino-Pyrazoles in Medicinal Chemistry: A Review 1-gen-2023 Lusardi, Matteo; Spallarossa, Andrea; Brullo, Chiara
An update on dual Src/Abl inhibitors 1-gen-2012 Musumeci, Francesca; Schenone, Silvia; Brullo, Chiara; Botta, M.
An Update on JAK Inhibitors 1-gen-2019 Musumeci, Francesca; Greco, Chiara; Giacchello, Ilaria; Fallacara, Anna Lucia; Ibrahim, Munjed M; Grossi, Giancarlo; Brullo, Chiara; Schenone, Silvia
Analogs, formulations and derivatives of imatinib: A patent review 1-gen-2015 Musumeci, Francesca; Schenone, Silvia; Grossi, Giancarlo; Brullo, Chiara; Sanna, Monica
Antimicrobial Evaluation of New Pyrazoles, Indazoles and Pyrazolines Prepared in Continuous Flow Mode 1-gen-2023 Burke, Adam; Di Filippo, Mara; Spiccio, Silvia; Schito, ANNA MARIA; Caviglia, Debora; Brullo, Chiara; Baumann, Marcus
Antiproliferative Imidazo-Pyrazole-Based Hydrogel: A Promising Approach for the Development of New Treatments for PLX-Resistant Melanoma 1-gen-2023 Alfei, Silvana; Milanese, Marco; Brullo, Chiara; Valenti, Giulia Elda; Domenicotti, Cinzia; Russo, Eleonora; Marengo, Barbara
ATP-competitive inhibitors of mTOR: an update. 1-gen-2011 Schenone, Silvia; Brullo, Chiara; Musumeci, Francesca; Radi, M; Botta, M.
Bcr-Abl tyrosine kinase inhibitors: A patent review 1-gen-2015 Desogus, Andrea; Schenone, Silvia; Brullo, Chiara; Tintori, Cristina; Musumeci, Francesca
Biological evaluation of pyrazolyl-urea and dihydro-imidazopyrazolyl-urea derivatives as potential anti-angiogenetic agents in the treatment of neuroblastoma 1-gen-2020 Marengo, B.; Meta, E.; Brullo, C.; de Ciucis, C.; Colla, R.; Speciale, A.; Garbarino, O.; Bruno, O.; Domenicotti, C.
Biologically driven synthesis of pyrazolo[3,4-d]pyrimidines as protein kinase inhibitors: an old scaffold as a new tool for medicinal chemistry and chemical biology studies 1-gen-2014 Schenone, Silvia; Radi, M; Musumeci, Francesca; Brullo, Chiara; Botta, M.
Breakthroughs in Medicinal Chemistry: New Targets and Mechanisms, New Drugs, New Hopes–7 1-gen-2020 Gütschow, M.; Vanden Eynde, J. J.; Jampilek, J.; Kang, C.; Mangoni, A.; Fossa, P.; Karaman, R.; Trabocchi, A.; Scott, P. J. H.; Reynisson, J.; Rapposelli, S.; Galdiero, S.; Winum, J. Y.; Brullo, C.; Prokai-Tatrai, K.; Sharma, A. K.; Schapira, M.; Azuma, Y. T.; Cerchia, L.; Spetea, M.; Torri, G.; Collina, S.; Geronikaki, A.; García-Sosa, A. T.; Vasconcelos, M. H.; Sousa, M. E.; Kosalec, I.; Tuccinardi, T.; Duarte, I. F.; Salvador, J. A. R.; Bertinaria, M.; Pellecchia, M.; Amato, J.; Rastelli, G.; Gomes, P. A. C.; Guedes, R. C.; Sabatier, J. M.; Estévez-Braun, A.; Pagano, B.; Mangani, S.; Ragno, R.; Kokotos, G.; Brindisi, M.; González, F. V.; Borges, F.; Miloso, M.; Rautio, J.; Muñoz-Torrero, D.
Btk inhibitors: a medicinal chemistry and drug delivery perspective 1-gen-2021 Brullo, C.; Villa, C.; Tasso, B.; Russo, E.; Spallarossa, A.